布莱恩·丹尼文特

Bryan Dunnivant joined Lilly Ventures in 2005 and currently serves as the Managing Director. He also serves as the Director on the boards of Bayhill Therapeutics， Fast Track Systems， and Med Manage.

Mr.Dunnivant has more than 25 years of experience in the Biopharmaceutical industry and has held leadership roles across multiple disciplines including Finance， Strategy， R&D， International Operations， New Business Development， and Venture Investing.

Prior to joining Lilly Ventures， he was the Chief Operating Officer for e.Lilly， a division of Eli Lilly and Company focused on Innovation， New Business Models， and Spin-Outs. During his tenure at e.Lilly， Mr.Dunnivant was involved in the founding， startup， incubation， and financing of a number of new life science businesses including Indigo BioSystems， Maaguzi， and Collaborative Drug Discovery.

Mr.Dunnivant received his B.S. in Chemical Engineering from the University of Illinois and Master in Business Administration from Butler University.